We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Safety of RAD001 in Chinese Patients With Metastatic Renal Cell Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01152801
Recruitment Status : Completed
First Posted : June 29, 2010
Last Update Posted : June 24, 2014
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )